ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.727,20
0,48%
S&P 500
6.054,09
0,24%
Dow Jones
44.833,06
0,27%
Euro vs US Dollar
1,04158
-0,08%
Bitcoin
105.244,66
1,45%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. HCW Biologics Inc (HCWB)

  7. HCW Biologics Inc (HCWB) News

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HCWB
DatumZeitQuelleÜberschriftSymbolFirma
15/01/202513h00GlobeNewswire Inc.HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025NASDAQ:HCWBHCW Biologics Inc
23/12/202414h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
23/12/202414h10GlobeNewswire Inc.HCW Biologics Inc. Received NASDAQ Staff Determination LetterNASDAQ:HCWBHCW Biologics Inc
05/12/202422h37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HCWBHCW Biologics Inc
22/11/202422h53Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:HCWBHCW Biologics Inc
22/11/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
20/11/202422h42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
20/11/202418h54Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:HCWBHCW Biologics Inc
19/11/202403h27GlobeNewswire Inc.HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ RulesNASDAQ:HCWBHCW Biologics Inc
18/11/202413h00GlobeNewswire Inc.HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product CandidateNASDAQ:HCWBHCW Biologics Inc
18/11/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
14/11/202423h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
14/11/202423h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
14/11/202422h40GlobeNewswire Inc.HCW Biologics Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
20/09/202423h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
23/08/202422h35Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HCWBHCW Biologics Inc
23/08/202422h30GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - CorrectionNASDAQ:HCWBHCW Biologics Inc
14/08/202422h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
14/08/202422h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
14/08/202422h35GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
12/08/202422h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
18/07/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
17/06/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
17/06/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
20/05/202422h36Edgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]NASDAQ:HCWBHCW Biologics Inc
15/05/202423h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
15/05/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
15/05/202422h39GlobeNewswire Inc.HCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
15/05/202422h35Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HCWBHCW Biologics Inc
01/04/202422h10GlobeNewswire Inc.HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business HighlightsNASDAQ:HCWBHCW Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:HCWB

Kürzlich von Ihnen besucht

COIN
ETHUSD
Ethereum
TG
TUI1
Tui
NASDAQ
TSLA
Tesla
NYSE
MRK
Merck
COIN
ADAUSD
Cardano
NYSE
MCD
McDonalds
TG
NOV
Novo Nordisk
AMEX
SPY
SPDR S&P 500
TG
ALV
Allianz
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
TG
CBK
Commerzbank
COIN
XRPUSD
Ripple
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten